| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1052388547 |
| P356 | DOI | 10.1038/SJ.GT.3302939 |
| P8608 | Fatcat ID | release_ifsohjwnpbez7g4cfubspiex2i |
| P698 | PubMed publication ID | 17443215 |
| P5875 | ResearchGate publication ID | 6385919 |
| P2093 | author name string | Van Bockstaele E | |
| Louboutin JP | |||
| Strayer DS | |||
| Reyes BA | |||
| Agrawal L | |||
| P2860 | cites work | Transfer of a foreign gene into the brain using adenovirus vectors | Q64377820 |
| Transduction of murine cerebellar neurons with recombinant FIV and AAV5 vectors | Q74285552 | ||
| Immune responses against SIV envelope glycoprotein, using recombinant SV40 as a vaccine delivery vector | Q77148428 | ||
| Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy | Q24535690 | ||
| In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector | Q29547503 | ||
| Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER | Q29620552 | ||
| Viral vectors for gene therapy in Parkinson's disease | Q32113689 | ||
| Gene therapy using SV40-derived vectors: what does the future hold? | Q33755140 | ||
| Vestibular brainstem disorders: clinical syndromes in roll plane and their model simulation | Q34523136 | ||
| Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system. | Q35111738 | ||
| Adenoviral vectors for gene replacement therapy | Q35882884 | ||
| HSV trafficking and development of gene therapy vectors with applications in the nervous system | Q36134871 | ||
| Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection | Q36720691 | ||
| Neonatal gene transfer leads to widespread correction of pathology in a murine model of lysosomal storage disease. | Q37181003 | ||
| Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector | Q37251114 | ||
| Bound simian virus 40 translocates to caveolin-enriched membrane domains, and its entry is inhibited by drugs that selectively disrupt caveolae | Q37383445 | ||
| Targeting CCR5 with siRNAs: using recombinant SV40-derived vectors to protect macrophages and microglia from R5-tropic HIV. | Q38953240 | ||
| Widespread gene delivery and structure-specific patterns of expression in the brain after intraventricular injections of neonatal mice with an adeno-associated virus vector | Q39611260 | ||
| Role of nuclear pore complex in simian virus 40 nuclear targeting. | Q40043437 | ||
| Antioxidant enzyme gene delivery to protect from HIV-1 gp120-induced neuronal apoptosis | Q40251050 | ||
| Gene therapy for human alpha1-antitrypsin deficiency in an animal model using SV40-derived vectors | Q40504864 | ||
| Targeted transduction patterns in the mouse brain by lentivirus vectors pseudotyped with VSV, Ebola, Mokola, LCMV, or MuLV envelope proteins | Q40583034 | ||
| Inhibition of HIV-1 in the central nervous system by IFN-alpha2 delivered by an SV40 vector. | Q40625143 | ||
| Local actin polymerization and dynamin recruitment in SV40-induced internalization of caveolae | Q40736924 | ||
| Production and neurotropism of lentivirus vectors pseudotyped with lyssavirus envelope glycoproteins. | Q40788905 | ||
| A replication-deficient rSV40 mediates liver-directed gene transfer and a long-term amelioration of jaundice in gunn rats | Q40845754 | ||
| Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease | Q40846012 | ||
| Extracellular simian virus 40 transmits a signal that promotes virus enclosure within caveolae | Q40982003 | ||
| Decreased lysosomal storage in the adult MPS VII mouse brain in the vicinity of grafts of retroviral vector-corrected fibroblasts secreting high levels of β-glucuronidase | Q41102578 | ||
| Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain | Q42280576 | ||
| X-linked vacuolated myopathy : TNF-alpha and IFN-gamma expression in muscle fibers with MHC class I on sarcolemma | Q42856618 | ||
| Rabies virus glycoprotein pseudotyping of lentiviral vectors enables retrograde axonal transport and access to the nervous system after peripheral delivery | Q43685007 | ||
| Reversal of pathology in the entire brain of mucopolysaccharidosis type VII mice after lentivirus-mediated gene transfer. | Q44267005 | ||
| Self-complementary adeno-associated virus serotype 2 vector: global distribution and broad dispersion of AAV-mediated transgene expression in mouse brain | Q44686125 | ||
| Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system | Q45007196 | ||
| Systemic mannitol-induced hyperosmolality amplifies rAAV2-mediated striatal transduction to a greater extent than local co-infusion | Q45236560 | ||
| Immunology of gene therapy with adenoviral vectors in mouse skeletal muscle. | Q45270141 | ||
| Characterization of intrastriatal recombinant adeno-associated virus-mediated gene transfer of human tyrosine hydroxylase and human GTP-cyclohydrolase I in a rat model of Parkinson's disease. | Q45756120 | ||
| Gene transfer to rodent brain with recombinant adenoviral vectors: effects of infusion parameters, infectious titer, and virus concentration on transduction volume | Q45757267 | ||
| Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector | Q45769447 | ||
| Inhibiting AIDS in the central nervous system: gene delivery to protect neurons from HIV. | Q45862705 | ||
| Sustained production of beta-glucuronidase from localized sites after AAV vector gene transfer results in widespread distribution of enzyme and reversal of lysosomal storage lesions in a large volume of brain in mucopolysaccharidosis VII mice. | Q45864505 | ||
| Efficient gene transfer to hematopoietic progenitor cells using SV40-derived vectors | Q45868429 | ||
| Use of SV40-based vectors to transduce foreign genes to normal human peripheral blood mononuclear cells | Q45881612 | ||
| Using gene delivery to protect HIV-susceptible CNS cells: inhibiting HIV replication in microglia. | Q48687135 | ||
| P433 | issue | 12 | |
| P304 | page(s) | 939-949 | |
| P577 | publication date | 2007-04-19 | |
| P1433 | published in | Gene Therapy | Q15763095 |
| P1476 | title | Strategies for CNS-directed gene delivery: in vivo gene transfer to the brain using SV40-derived vectors | |
| P478 | volume | 14 |
| Q36458373 | A rat model of human immunodeficiency virus 1 encephalopathy using envelope glycoprotein gp120 expression delivered by SV40 vectors |
| Q52623530 | Blood-brain barrier abnormalities caused by HIV-1 gp120: mechanistic and therapeutic implications. |
| Q30437835 | Current approaches to enhance CNS delivery of drugs across the brain barriers |
| Q42856452 | Efficient CNS gene delivery by intravenous injection |
| Q28579694 | Enhancement of dorsal hippocampal activity by knockdown of HCN1 channels leads to anxiolytic- and antidepressant-like behaviors |
| Q36450108 | Gene delivery of antioxidant enzymes inhibits human immunodeficiency virus type 1 gp120-induced expression of caspases |
| Q45081316 | Gene transfer to the cerebellum |
| Q45867822 | Gene transfer to the rhesus monkey brain using SV40-derived vectors is durable and safe |
| Q36450103 | HIV-1 gp120-induced injury to the blood-brain barrier: role of metalloproteinases 2 and 9 and relationship to oxidative stress |
| Q33532297 | Immunohistochemical detection of transgene expression in the brain using small epitope tags |
| Q45870327 | Intracisternal rSV40 administration provides effective pan-CNS transgene expression |
| Q28766660 | Methods, potentials, and limitations of gene delivery to regenerate central nervous system cells |
| Q36335033 | Oxidative Stress Is Associated with Neuroinflammation in Animal Models of HIV-1 Tat Neurotoxicity |
| Q33730464 | Persistent expression of FLAG-tagged micro dystrophin in nonhuman primates following intramuscular and vascular delivery |
| Q54408207 | Postnatal soluble FGFR3 therapy rescues achondroplasia symptoms and restores bone growth in mice. |
| Q45871733 | Protecting neurons from HIV-1 gp120-induced oxidant stress using both localized intracerebral and generalized intraventricular administration of antioxidant enzymes delivered by SV40-derived vectors |
| Q28576511 | Role of CCR5 and its ligands in the control of vascular inflammation and leukocyte recruitment required for acute excitotoxic seizure induction and neural damage |
| Q26829535 | Role of Oxidative Stress in HIV-1-Associated Neurocognitive Disorder and Protection by Gene Delivery of Antioxidant Enzymes |
| Q27023715 | The glial response to intracerebrally delivered therapies for neurodegenerative disorders: is this a critical issue? |
| Q37781306 | Thinking about HIV: the intersection of virus, neuroinflammation and cognitive dysfunction |
| Q40292313 | Transfection of primary brain capillary endothelial cells for protein synthesis and secretion of recombinant erythropoietin: a strategy to enable protein delivery to the brain |
Search more.